QT Imaging (NASDAQ:QTI – Get Free Report) and Inogen (NASDAQ:INGN – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, dividends, earnings, valuation, profitability, risk and institutional ownership.
Volatility and Risk
QT Imaging has a beta of 0.02, meaning that its stock price is 98% less volatile than the S&P 500. Comparatively, Inogen has a beta of 1.5, meaning that its stock price is 50% more volatile than the S&P 500.
Earnings & Valuation
This table compares QT Imaging and Inogen”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| QT Imaging | $18.92 million | 1.75 | -$21.08 million | ($1.57) | -1.54 |
| Inogen | $354.30 million | 0.47 | -$22.75 million | ($0.90) | -6.97 |
QT Imaging has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
24.2% of QT Imaging shares are held by institutional investors. Comparatively, 89.9% of Inogen shares are held by institutional investors. 25.4% of QT Imaging shares are held by insiders. Comparatively, 2.5% of Inogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Profitability
This table compares QT Imaging and Inogen’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| QT Imaging | -77.25% | -1,202.69% | -46.76% |
| Inogen | -6.94% | -13.17% | -8.36% |
Analyst Ratings
This is a breakdown of current ratings for QT Imaging and Inogen, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| QT Imaging | 1 | 1 | 2 | 0 | 2.25 |
| Inogen | 1 | 0 | 0 | 1 | 2.50 |
QT Imaging presently has a consensus target price of $8.00, indicating a potential upside of 231.95%. Given QT Imaging’s higher probable upside, equities research analysts clearly believe QT Imaging is more favorable than Inogen.
Summary
Inogen beats QT Imaging on 9 of the 15 factors compared between the two stocks.
About QT Imaging
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.
About Inogen
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
